Interpretable Deep Supramolecular Language Modeling for Cocrystal Design: PCA-Augmented DeepCocrystal Screening of Picolinamide, Nicotinamide, and Isonicotinamide Systems
Bahadır Bozkurt, Ayberk Yilmaz, Gulce Ogruc Ildiz, Rui Fausto, Shiling Yuan · 2026
Read Interpretable Deep Supramolecular Language Modeling for Cocrystal Design: PCA-Augmented DeepCocrystal Screening of Picolinamide, Nicotinamide, and Isonicotinamide Systems by Bahadır Bozkurt, Ayberk Yilmaz, Gulce Ogruc Ildiz, Rui Fausto, Shiling Yuan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13610686.txt.
Description
Bahadır Bozkurt and four colleagues add a lens to an AI system that predicts which pairs will form drug cocrystals. Cocrystals can fix a drug's solubility or stability, but choosing a partner molecule is guesswork. The underlying DeepCocrystal model ranks candidate coformers for three related drug-like molecules. The new layer applies principal component analysis to the feature space without changing any prediction, to expose what drives them.
Three drivers dominated matching: hydrogen-bond matching, polarity matching, and aromatic surface contact. A simple acidity-based filter weeded out pairs likely to form salts instead of cocrystals. Of 137 pairs left positive or uncertain, the filter kept 46 as high-probability cocrystal candidates and 39 as uncertain with salt excluded. Another 34 landed in a salt-cocrystal gray zone, and 7 were flagged as salt risks. The authors pitch the combined approach as transparent, letting chemists prioritize coformers with reasons attached.
Catalog record
| CREATOR | Bahadır Bozkurt, Ayberk Yilmaz, Gulce Ogruc Ildiz, Rui Fausto, Shiling Yuan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |